Multiple myeloma trials, also abroad
705 open Multiple myeloma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) has 5 sites in Slovakia and runs in 27 countries. If a site near you is full, another one may still take people.
See MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) in all 27 countries